Mauritius Based LTS Investment Fund Picks up Stake in Bliss GVS Pharma Ltd.
| Wednesday | 13th January, 2021
As per Bulk deal data available on NSE, Mauritius based LTS Investment Fund has picked up stake in BSE and NSE listed Bliss GVS Pharma Ltd.
Earlier, Life Corporation of India (LIC) had also raised stake in Bliss GVS Pharma.
Today Bliss GVS is among the world leaders in Suppositories and Pessaries dosage forms with one of the largest product portfolio in this segment.
Bliss GVS manufacturing plants are certified to be cGMP compliant by local and international standards: EU GMP, WHO GMP, OHSAS-18001 : 2007 and ISO-14001 : 2004.
Bliss GVS Pharma has 8 manufacturing facilities, over 20 therapeutic categories and over 250 products.